EVIK is expanding personnel and equipment capacity of both R & D and production. We are adding to our expertise of reagent formulation to continue to improve our Lyophilization success.
The Call For Study Proposals Strategic Objectives are:
1) To promote directed research evaluating the role of lab medicine on clinical outcomes
2) To build awareness and understanding on the critical role of lab medicine plays in healthcare outcomes.
Terms and conditions for the Grant are described.
Planet Innovation (PI), a healthtech innovation and manufacturing company, has launched its NeoSync™ connectivity solution for diagnostic and medical devices, at the AACC Annual Scientific Meeting & Clinical Lab Expo.
Linxens, a global expert in the manufacture of micro-connectors for smart cards and RFID antennas, announces that their electrodes are a cost-effective & high-quality alternative to standard gold electrodes.
CHICAGO, July 26, 2022 /PRNewswire/ -- AACC 2022 Open Lab Solutions, Inc., is announcing the formation of a new division, AMCAR Scientific, that will focus on an expanding product line of plastic consumables used in the medical industry. OLS is exhibiting within booth #3257 at the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2022) at the McCormick Place Convention Center in Chicago, July 24 – 28th.
Tesi Group will exhibit at the AACC Annual Scientific Meeting & Clinical Lab Expo alongside GPI USA, joined by Italian parent company Gpi Group, following up on an agreement recently signed by the two parties for the acquisition at the end of Q3 of 65% of the share capital of TESI by Gpi Group.
ZeptoMetrix®, an Antylia Scientific™ company, today launches the NATtrol™ Bacteriophage MS2 quantitative stock: NATMS2-STQ. This product is intended for use as an internal process control for molecular diagnostic assays.
The Georgia Department of Economic Development announced the winners of their annual Globe Awards on May 23rd, 2022. Among the awards were three top designations for Exporter of the Year. Athens Research and Technology, Inc. (ART) was the recipient of the Exporter of the Year award for a business with less than 20 employees. The award was presented at the laboratory to ART's CEO, John Mitchell, on May 25th by Mary Waters, the Deputy Commissioner of International Trade for the State of Georgia.
ZeptoMetrix®, an Antylia Scientific™ company, today launches its new external run control for Flu, RSV, SARS-CoV-2: NATFRC-ERC. This third-party molecular quality control can be used by laboratories to monitor the continued performance of their multiplexed respiratory assays. It is available for pre-order.
The technology housed in the new Long Beamline Building will lead to more efficient solar cells, longer-lasting batteries, more durable materials for airplanes and much more.
Today, Gilson announced a new UV-VIS detector to its VERITY® line of purification systems. The VERITY® 1741 UV-VIS Detector is specifically designed with the needs of semi-preparative and preparative HPLC customers in mind.
LumiraDx, a next-generation point of care diagnostics company will be hosting an industry workshop at this week’s American Association for Clinical Chemistry (AACC) Annual Conference in Chicago. The workshop, held on July 27th, will include data-backed insights on the impact of LumiraDx’s advanced microfluidic technology over lateral flow point-of-care antigen tests, and the role of these rapid immunoassays in response to the COVID-19 pandemic.
Cytovale®, a medical diagnostics company focused on providing rapid and insightful tools to improve early detection of fast-moving and immune-mediated diseases, will reveal its 510(k) pending Cytovale system and 10-minute IntelliSep® sepsis risk stratification test at the American Association for Clinical Chemistry (AACC) annual meeting, where new data featuring the test will also be shared. The instrument can be seen in the Cytovale booth, no. 5045, in the exhibit hall during Clinical Lab Expo hours. The IntelliSep test was recently named an AACC Disruptive Technology Award Semifinalist and is also being featured in the Disruptive Tech area of the exhibit hall during the meeting.
BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, today announced the launch of its digital Connected Diagnostics Platform at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo. This comprehensive, end-to-end platform is a one-stop shop for in vitro diagnostics manufacturers that streamlines workflows, accelerates revenue growth and drives innovation.
Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic™ Collection Device focused on small volume blood collection.
DiaSorin (FTSE MIB: DIA) announced today the FDA 510(k) clearance and the commercial launch in the US of the host-protein signature-based assay LIAISON® MeMed BV®